Cite
Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600 melanoma patients
MLA
Jean-Claude Alvarez, et al. “Monitoring of Plasma Concentrations of Dabrafenib and Trametinib in Advanced BRAFV600 Melanoma Patients.” Annales de Dermatologie et de Vénéréologie, vol. 149, Mar. 2022, pp. 32–38. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f20aa12864f50c66dbcd4196e4c4ce34&authtype=sso&custid=ns315887.
APA
Jean-Claude Alvarez, Elisa Funck-Brentano, Philippe Saiag, A. Beauchet, Christian Funck-Brentano, & M. Raynal. (2022). Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600 melanoma patients. Annales de Dermatologie et de Vénéréologie, 149, 32–38.
Chicago
Jean-Claude Alvarez, Elisa Funck-Brentano, Philippe Saiag, A. Beauchet, Christian Funck-Brentano, and M. Raynal. 2022. “Monitoring of Plasma Concentrations of Dabrafenib and Trametinib in Advanced BRAFV600 Melanoma Patients.” Annales de Dermatologie et de Vénéréologie 149 (March): 32–38. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f20aa12864f50c66dbcd4196e4c4ce34&authtype=sso&custid=ns315887.